Project The AMARANTH Study – A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group,…

Basic data

Acronym:
The AMARANTH Study
Title:
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer´s Disease
Duration:
01/05/2015 to 30/04/2017
Abstract / short description:
In der Studie wird die Wirksamkeit einer 24-monatigen Therapie mit einem BACE1-inhibitor bei Patienten mit früher Alzheimer-Erkrankung untersucht.
Keywords:
Alzheimer
BACE1-Inhibitor

Involved staff

Managers

Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Epileptology
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine

Funders

Waltham, Massachusetts, United States of America
Help

will be deleted permanently. This cannot be undone.